1. Walters EH, Gibson PG, Lasserson TJ, Walters JA: Long-acting beta2-agonists for chronic asthma in adults and children where background therapy contains varied or no inhaled corticosteroid. Cochrane Database Syst Rev. 2007, 1: 1-340.
2. Castle W, Fuller R, Hall J, Palmer J: Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment. BMJ. 1993, 306: 1034-1037.
3. Levenson M: Long-acting beta-agonists and adverse asthma events meta-analysis: Briefing package for joint meeting of the Pulmonary-Allergy Drug Advisory Committee and Pediatric Advisory Committee on December 10-11, 2008. 2012, Available from URL: http://www.fda.gov/ohrms/dockets/ac/08/briefing/2008-4398b1-01-FDA.pdf [cited 2012 Oct 4]
4. Nelson HS, Weiss ST, Bleecker ER, Yancey SW, Dorinsky PM: The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest. 2006, 129: 15-26.
5. Cates CJ, Cates MJ: Regular treatment with formoterol for chronic asthma: serious adverse events. Cochrane Database Syst Rev. 2012, 4: CD006923